Dihydroergotamine Gene Set

Dataset	DrugBank Drug Targets
Category	physical interactions
Type	drug
Description	Ergotamine in which a single bond replaces the double bond between positions 9 and 10. A semisynthetic ergot alkaloid with weaker oxytocic and vasoconstrictor properties than ergotamine, it is used (as the methanesulfonic or tartaric acid salts) for the treatment of migraine and orthostatic hypotension. (Chemical Entities of Biological Interest Ontology, CHEBI_4562)
External Link	http://www.drugbank.ca/drugs/DB00320
Similar Terms
Downloads & Tools

Genes

6 interacting proteins for the Dihydroergotamine drug from the curated DrugBank Drug Targets dataset.

Symbol	Name
ABCB1	ATP-binding cassette, sub-family B (MDR/TAP), member 1
ADRA2A	adrenoceptor alpha 2A
CYP3A4	cytochrome P450, family 3, subfamily A, polypeptide 4
HTR1B	5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
HTR1D	5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled
HTR2B	5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled